Analyst Price Targets — CLPT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 9, 2026 1:09 pm | Tom Stephan | Stifel Nicolaus | $16.00 | $13.47 | StreetInsider | Stifel Reiterates Buy Rating on Clearpoint Neuro Inc. (CLPT) |
| January 21, 2025 2:15 pm | Frank Takkinen | Lake Street | $30.00 | $15.44 | TheFly | ClearPoint Neuro price target raised to $30 from $17 at Lake Street |
| August 27, 2024 8:45 am | Frank Takkinen | Loop Capital Markets | $15.00 | $12.60 | StreetInsider | Clearpoint Neuro Inc. (CLPT) PT Raised to $15 at Lake Street Capital Markets |
| March 13, 2024 4:35 am | Mathew Blackman | Stifel Nicolaus | $9.00 | $7.17 | StreetInsider | Clearpoint Neuro Inc. (CLPT) PT Raised to $9 at Stifel |
Latest News for CLPT
ClearPoint Neuro remains a speculative Buy, offering leveraged exposure to gene therapy commercialization and neurosurgery navigation growth. Recent FDA feedback on uniQure's AMT-130 renews optimism for near-term revenue, but regulatory and partner execution risks persist. CLPT's Q1 organic growth slowed, cash burn accelerated, and full-year 2026 revenue guidance ($52–$56M) disappointed versus expectations.
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including both focused ultrasound hardware and ClearPoint Navigation Software and Robotics SOLANA BEACH, CA / ACCESS Newswire / May 27, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene…
ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for ClearPoint Neuro (CLPT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLPT.
U.S. House Trading
No House trades found for CLPT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.